NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for angiogenesis inhibitor


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data from G. Zahn and colleagues advance knowledge in choroidal neovascularization
2009 NOV 23 ... St., Chicago, IL 60610-0946, USA. Keywords: City:Berlin, Country:Germany, Angiogenesis, Angiography, Cardiology, Choroidal Neovascularization, Clinical Trials, Contrast Media, ... activity and tolerability of JSM6427, a potent and first selective small-molecule inhibitor of integrin alpha 5 beta 1, in monkey and rabbit models of choroidal neovascularization ...
Subject: Choroidal Neovascularization
Price: $3.00
*
New findings in glomerular disease described by S.G. Sayyed and co-researchers
2009 NOV 23 ... is a homeostatic chemokine with multiple roles in cell homing, tumour metastasis, angiogenesis and tissue regeneration after acute injuries. However, its role in chronic diseases ... role of CXCL12 in the progression of glomerular disease, we used the CXCL12-specific inhibitor NOX-A12, an L-enantiomeric RNA oligonucleotide (Spiegelmer). A mouse model of type 2 ...
Subject: Glomerular Disease
Price: $3.00
*
New mechanism explains how the body prevents formation of blood vessels
2009 NOV 23 ... platelets create a microenvironment in which the HRG fragment is able to function as an angiogenesis inhibitor." Data from so-called "knockout" mice, which lack HRG, support this ...
Subject: Uppsala University
View Free
Daily News
Article
Reports from University of Texas describe recent advances in proteomics
2009 NOV 23 ... and activator of transcription 3 (Stat3) participates in aberrant growth, survival, angiogenesis, and invasion signals and is a validated target for anticancer drug design. We are ... resulted in an IC50 of 69 nM, the highest affinity Stat3 inhibitor reported to date." Mandal and colleagues published their study in the ...
Subject: Proteomics
Price: $3.00
*
Reports outline atherosclerosis research from Tor Vergata University
2009 NOV 23 ... miR-217 induces a premature senescence-like phenotype and leads to an impairment in angiogenesis via inhibition of SirT1 and modulation of FoxO1 (forkhead box O1) and endothelial nitric ... The researchers concluded: "Our data pinpoint miR-217 as an endogenous inhibitor of SirT1, which promotes endothelial senescence and is potentially amenable to ...
Subject: Atherosclerosis
Price: $3.00
*
Research conducted by K.R. Lamontagne and co-researchers has updated our knowledge about vascular endothelial growth factor
2009 NOV 23 ... According to recent research published in the journal Angiogenesis, "Angiogenesis is a complex process that relies on a variety of growth factors and ... sorafenib, and suntinib. Our goal was to discover an orally available, selective VEGFR-2 inhibitor. A novel oxime, ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Research on obesity detailed by scientists at Gothenburg University, Sahlgrenska Academy
2009 NOV 16 ... According to a study from Gothenburg, Sweden, "Tenomodulin (TNMD), a putative angiogenesis inhibitor, is expressed in hypovascular connective tissues. Global gene expression scans show that ...
Subject: Obesity
Price: $3.00
*
Research on retinal neovascularization reported by scientists at University of South Carolina, Medical Department
2009 NOV 16 ... Parkway, Rockville, MD 20852-1606, USA. Keywords: United States, Columbia, Angiogenesis, Anticholesteremic, Antioxidant, Blindness, Enzymes, Fluvastatin, Free Radical ... Antioxidant, Blindness, Enzymes, Fluvastatin, Free Radical Scavenger, HMG-CoA Reductase Inhibitor, Ischemia, Ophthalmology, Protein Expression, Proteins, Proteomics, Reductase, Retinal ...
Subject: Retinal Neovascularization
Price: $3.00
*
Researchers from Mario Negri Institute for Pharmacological Research report on findings in ovarian cancer therapy
2009 NOV 23 ... York, NY 10010-1707, USA. Keywords: Italy, Milan, Ovarian Cancer Therapy, Angiogenesis, Anticancer Therapy, Antitumor Activity, Biotechnology, Drugs, Enzymes, Gynecology, ... to determine the effects of vandetanib, a small-molecule receptor tyrosine kinase inhibitor of vascular endothelial growth factor and epidermal growth factor receptor, on ...
Subject: Ovarian Cancer Therapy
View Free
Daily News
Article
Researchers' work from Tufts University focuses on abdominal aortic aneurysm
2009 NOV 16 ... CI1040. Furthermore, simvastatin and the ERK inhibitor U0126 reversed AngII-stimulated angiogenesis and MMP secretion by human umbilical vein endothelial cells," wrote Y.L. Zhang and ...
Subject: Abdominal Aortic Aneurysm
Price: $3.00
*
Scientists at University of Ghent target breast cancer
2009 NOV 23 ... inflammation, acts as an autocrine and paracrine growth factor, which promotes angiogenesis, metastasis, and subversion of immunity, and changes the response to hormones and to ... and MSK1, CBP/p300, Brg1, and Ezh2 cofactors. Complementation, silencing, and kinase inhibitor experiments further demonstrate involvement of AP-1 Fra-1/c-Jun and NF-kappa B p65/RelB ...
Subject: Breast Cancer
Price: $3.00
*
Scientists at University of New Mexico, Medical Department discuss research in angiogenesis
2009 NOV 16 ... According to recent research from the United States, "Angiogenesis, or the formation of new retinal blood vessels, is a key feature of many proliferative ... The aim of the present study was to investigate the role of the serine proteinase inhibitor plasminogen activator inhibitor-1 (PAI-1) in facilitating retinal angiogenesis." ...
Subject: Angiogenesis
Price: $3.00
*
Studies from E.M. Conn et al have provided new data on angiogenesis
2009 NOV 16 ... exhibited increased angiogenic potential in avian and murine models. PC-hi/diss angiogenesis and intravasation were dependent on increased secretion of vascular endothelial growth ... blocked uPA activity. These processes were similarly sensitive to aprotinin, a potent inhibitor of serine proteases, including uPA-generated plasmin," wrote E.M. Conn and colleagues. ...
Subject: Angiogenesis
Price: $3.00
*
Studies from Harvard University update current data on angiogenesis
2009 NOV 16 ... lipoxin (LX) A4 analog (ATLa), resolving (Rv) D1, and RvE1, in regulating angiogenesis in a murine model," researchers in the United States report. "ATLa and ... addition, ATLa directly inhibits VEGF-A-mediated angiogenesis and is the most potent inhibitor of NV among this new genus of dual anti-inflammatory and pro-resolving lipid mediators. ...
Subject: Angiogenesis
Price: $3.00
*
Studies from M.L. Maitland et al have provided new data on vascular endothelial growth factor
2009 NOV 16 ... Floor, Philadelphia, PA 19106-4404, USA. Keywords: United States, Chicago, Angiogenesis, Blood Pressure, Cancer, Clinical Trial Research, Drugs, Experimental Design, ... but could be important in optimizing the therapeutic index of VEGF signaling pathway inhibitor therapy. (Clin Cancer Res 2009;15(19):6250-7)." Maitland and colleagues ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*
Study data from Okayama University update knowledge of angiogenesis
2009 NOV 23 ... diabetic nephropathy has been reported. Vasohibin-1 (VASH-1) is a unique endogenous angiogenesis inhibitor that is induced in endothelial cells by proangiogenic factors," scientists in Okayama, ...
Subject: Angiogenesis
Price: $3.00
*
Study findings from A. Mazzocca et al provide new insights into angiogenesis
2009 NOV 16 ... of LY2109761 was associated with inhibition of molecular pathways involved in neo-angiogenesis and tumor growth of HCC. This anti-angiogenic effect is more effective than that of ... growth factor beta (TGF-beta) signaling pathway in HCC with LY2109761, a kinase inhibitor of TGF-beta receptor I kinase," investigators in Bari, Italy report. "The ...
Subject: Angiogenesis
Price: $3.00
*
Study results from Kyung-Hee University, Medical Department broaden understanding of angiogenesis
2009 NOV 16 ... neovascularization is regulated not only by stimulators, but also by inhibitors of angiogenesis and might be the result of a net balance between the positive and negative regulators. ... a net balance between the positive and negative regulators. Endostatin (ES) is a potent inhibitor of angiogenesis." "The expression of ES has not been investigated in ...
Subject: Angiogenesis
Price: $3.00
*
Study results from Yeungnam University update understanding of vascular endothelial growth factor
2009 NOV 23 ... exerts its inhibitory action in vascular endothelial growth factor (VEGF)-induced angiogenesis signaling," scientists writing in the Journal of Pharmacological Sciences report. ... VEGF-induced MMP-2 and MT1-MMP expression were comparable to those of the NADPH oxidase inhibitor diphenylene iodium (10 mc M) and ERK inhibitor PD98056 (10 mc M). Furthermore, in an in ...
Subject: Vascular Endothelial Growth Factor
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login